Nuvation Bio Inc. (NUVB-WT)

USD 0.16

(0.65%)

Net Debt Summary of Nuvation Bio Inc.

  • Nuvation Bio Inc.'s latest annual net debt in 2023 was -38.64 Million USD , up 60.1% from previous year.
  • Nuvation Bio Inc.'s latest quarterly net debt in 2024 Q2 was 255.33 Million USD , up 924.25% from previous quarter.
  • Nuvation Bio Inc. reported annual net debt of -96.83 Million USD in 2022, up 25.14% from previous year.
  • Nuvation Bio Inc. reported annual net debt of -129.36 Million USD in 2021, down -334.78% from previous year.
  • Nuvation Bio Inc. reported quarterly net debt of -30.97 Million USD for 2024 Q1, up 19.83% from previous quarter.
  • Nuvation Bio Inc. reported quarterly net debt of -38.64 Million USD for 2023 Q4, down -93.88% from previous quarter.

Annual Net Debt Chart of Nuvation Bio Inc. (2023 - 2018)

Historical Annual Net Debt of Nuvation Bio Inc. (2023 - 2018)

Year Net Debt Net Debt Growth
2023 -38.64 Million USD 60.1%
2022 -96.83 Million USD 25.14%
2021 -129.36 Million USD -334.78%
2020 -29.75 Million USD -757.74%
2019 -3.46 Million USD -850.87%
2018 462 Thousand USD 0.0%

Peer Net Debt Comparison of Nuvation Bio Inc.

Name Net Debt Net Debt Difference
ADC Therapeutics SA -154.22 Million USD 74.944%
Alto Neuroscience, Inc. 68.91 Million USD 156.072%
Annovis Bio, Inc. -5.75 Million USD -571.484%
Biohaven Pharmaceutical Holding Company Ltd. -218.84 Million USD 82.343%
Ginkgo Bioworks Holdings, Inc. -707.09 Million USD 94.535%
Nuvation Bio Inc. -38.64 Million USD -0.0%
Arcus Biosciences, Inc. -116 Million USD 66.688%
Theriva Biologics, Inc. -21.02 Million USD -83.808%
Zymeworks Inc. -130.83 Million USD 70.465%